|
Symbol Name ID |
Bcas2
BCAS2 pre-mRNA processing factor MGI:1915433 |
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Bcas2tm1.1Lil/Bcas2tm1.1Lil involves: C57BL/6 * SJL |
normal mortality/aging | J:239876 |
| Bcas2tm1.1Lil/Bcas2tm1.1Lil Tg(Ddx4-cre)1Ptch/0 Not Specified |
abnormal female meiosis | J:324155 |
| abnormal oocyte morphology | J:324155 | |
| abnormal oogenesis | J:324155 | |
| decreased superovulation rate | J:324155 | |
| decreased tertiary ovarian follicle number | J:324155 | |
| female infertility | J:324155 | |
| impaired fertilization | J:324155 | |
| impaired ovarian folliculogenesis | J:324155 | |
| increased primary ovarian follicle number | J:324155 | |
| increased secondary ovarian follicle number | J:324155 | |
| small ovary | J:324155 | |
| Bcas2tm1.1Lil/Bcas2tm1.1Lil Tg(Zp3-cre)3Mrt/0 involves: 129 * C57BL/6 * FVB/N * SJL |
female infertility | J:239876 |
| maternal effect | J:239876 | |
| normal mortality/aging | J:239876 | |
| Bcas2tm1Lil/Bcas2tm1Lil Not Specified |
lethality, complete penetrance | J:239876 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||